Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001817 |
---|---|
Receipt number | R000002193 |
Scientific Title | Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer. |
Date of disclosure of the study information | 2009/04/01 |
Last modified on | 2014/01/08 13:17:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/03/30 17:16:47 | ||
2 | Update | 2009/10/08 21:26:46 | Recruitment status |
|
3 | Update | 2014/01/08 13:17:47 | Recruitment status |